1.Effects of benazepril on apoptosis and expression of Bax and Bcl-2 in kidney of diabetic rats with different blood glucose levels
Ke-Ke JIN ; Yan-Hong LIN ; Jing-Ye PAN ; Wan-Tie WANG ; Da-Wang WANG ; Yi-Xiao XU ;
Chinese Journal of Endocrinology and Metabolism 2001;0(05):-
Diabetic rats were induced by intraperitoneal injection of streptozotocin.TUNEL and immunohistochemistry results showed that the renal tubular cell apoptosis index(AI)and Bax protein expression were significantly reduced,and the Bcl-2 protein expression in glomeruli was significantly increased in diabetic rats with stable hyperglycemia treated by benazepril compared with diabetic rats with stable hyperglycemia treated by vehicle(all P
2.The selection and application of appendix in situ in the continent urinary diversion.
Ke-feng XIAO ; Da-le LIU ; Dao-heng ZHANG
Chinese Journal of Surgery 2004;42(10):577-579
OBJECTIVETo evaluate the elective method and the clinical experience of using appendix in situ in continent urinary diversion.
METHODS26 continent urinary diversions have been performed since 1990. Among them, 11 cases underwent the intussuscepted technique and other 15 cases underwent embedded technique.
RESULTSThe continent rate was 100% at the daytime among all the case, while intermittent incontinence occurred in 3 cases at night, which happened in the intussuscepted group. Other complications included catheterization difficulty in 3 cases, appendix perforation in 1 case, which happened in the embedded group, traction of the appendix into abdominal cavity in 1 case, and prolapse of the intussusepted appendix in 3 cases.
CONCLUSIONSThe embedded technique shows better results than the intussuscepted technique in term of continence. The embedded technique, using appendix in situ as an efferent loop, shows the advantages of easily performing, timesaving, better outcome in continence and less complication. We believe the technique of appendix in situ as an efferent loop is an ideal modality in urinary diversion operation.
Adult ; Aged ; Appendix ; surgery ; Cystectomy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Urinary Bladder Neoplasms ; surgery ; Urinary Bladder, Neurogenic ; surgery ; Urinary Diversion ; methods ; Urinary Reservoirs, Continent
3.Locking internal fixator with minimally invasive plate osteosynthesis for the proximal and distal tibial fractures.
Da-Ke TONG ; Fang JI ; Xiao-Bing CAI
Chinese Journal of Traumatology 2011;14(4):233-236
OBJECTIVETo investigate the efficacy of the locking internal fixator (LIF), which includes the locking compression plate (LCP) and the less invasive stable system (LISS), in the proximal and distal tibial fractures.
METHODSWe did a retrospective study on a total of 98 patients with either proximal or distal tibial fractures from January 2003 to January 2007, who had received the operation with LIF by the minimally invasive plate osteosynthesis (MIPO) technique. The data consisted of 43 proximal tibial fractures (type AO41C3) and 55 distal tibial fractures (type AO43C3).
RESULTSNo complications were observed in all patients after operation. The mean healing time was 8.4 months (range 5-14 months). Only two cases of delayed union occurred at postoperative 10 months. No infections were reported after the definitive surgery even in the cases of open fractures. All patients reached a full range of motion at postoperative 6 to 9 months and regained the normal functions of knee and ankle joints.
CONCLUSIONUsing LIF in MIPO technique is a reliable approach towards the proximal and distal tibial fractures that are not suitable for intramedullary nailing.
Bone Plates ; Fracture Fixation, Internal ; Humans ; Minimally Invasive Surgical Procedures ; Retrospective Studies ; Tibial Fractures ; surgery
4.Enantioselective determinination of R-warfarin/S-warfarin in human plasma using liquid chromatography-tandem mass spectrometry and its application in a drug-drug interaction study.
Shu JIN ; Yi-Fan ZHANG ; Xiao-Yan CHEN ; Ke LIU ; Da-Fang ZHONG
Acta Pharmaceutica Sinica 2012;47(1):105-109
To study the drug-drug interaction of morinidazole and warfarin and its application, a sensitive and rapid liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed for the determination of R-warfarin/S-warfarin in human plasma. In a random, two-period crossover study, 12 healthy volunteers received a single oral dose of 5 mg racemic warfarin in the absence and presence of morinidazole. Blood samples were collected according to a pre-designed time schedule. R-warfarin, S-warfarin and methyclothiazide were extracted with ethylether : methylenechloride (3 : 2), then separated on a Astec Chirobiotic V (150 mm x 4.6 mm ID, 5 microm) column using 5 mmol x L(-1) ammonium acetate (pH 4.0) - acetonitrile as mobile phase at a flow-rate of 1.5 mL x min(-1). The mobile phase was splitted and 0.5 mL x min(-1) was introduced into MS. A tandem mass spectrometer equipped with electrospray ionization source was used as detector and operated in the negative ion mode. Quantification was performed using multiple reaction monitoring (MRM). The resolution of warfarin enantiomers is 1.56. The linear calibration curves for R-warfarin and S-warfarin both were obtained in the concentration range of 5 - 1 000 ng x mL(-1). Intra- and inter-day relative standard deviation (RSD) for R-warfarin and S-warfarin over the entire concentration range across three validation runs was both less than 10%, and relative error (RE) ranged from -4.9% to 0.7%, separately. The method herein described is effective and convenient, and suitable for the study of metabolic interaction between morinidazole and warfarin. The results showed that coadministration of warfarin with morinidazole did not affect the pharmacokinetics of either R-warfarin or S-warfarin.
Anticoagulants
;
blood
;
pharmacokinetics
;
Chromatography, Liquid
;
Drug Interactions
;
Humans
;
Nitroimidazoles
;
blood
;
pharmacokinetics
;
Spectrometry, Mass, Electrospray Ionization
;
Stereoisomerism
;
Tandem Mass Spectrometry
;
Warfarin
;
blood
;
pharmacokinetics
5.A clinical study of Yigu capsule in treating postmenopausal osteoporosis.
Rong-hua ZHANG ; Ke-ji CHEN ; Da-xiang LU ; Xiao-feng ZHU ; Xiao-chang MA
Chinese journal of integrative medicine 2005;11(2):97-103
OBJECTIVETo observe the efficacy and safety of Yigu capsule (YGC), a Chinese herbal compound preparation, in treating postmenopausal osteoporosis (PMO) and to explore its possible mechanism.
METHODSThe clinical study was conducted in a prospective, randomized, double blinded method lasting for 6 months with placebo and positive control. Two hundred and ten PMO patients with confirmed diagnosis were assigned into the YGC group, the calciferol group and the placebo group. Besides being administered element calcium, they were treated with YGC, calciferol capsule and placebo capsule respectively. And such symptoms as newly found fracture and ostealgia, bone mineral density (BMD) of the 2nd-4th lumbar vertebrae (L(2-4)) and upper femur, blood and urinary indexes for bone metabolism, sex hormone level and adverse reaction that occurred in patients were observed.
RESULTSIn the YGC group, the total effective rate was 95.50%, with no new occurrence of fractures, which was significantly better than that in the other two groups (P < 0.05). Moreover, in the YGC group, the increase rate of BMD was 9.83% in L(2-4), 4.09% in femoral neck, 4.60% in Wards triangle, 3.00% in greater trochanter, which was also better than that in the placebo group (P < 0.05, P < 0.01). As compared with the placebo group, levels in the YGC group of urinary oxyproline hydroxyproline/creatinine, urinary calcium/creatinine were significantly lower, serum and bone alkaline phosphatase, osteocalcin, estradiol and estradiol/testosterone were significantly higher, but no difference was shown in the comparison of testosterone level. In the observation period, no abnormality in blood or urine routine, liver or renal function was found. Only mild, transient gastro-intestinal response occurred in individual patients, but it did not affect the treatment.
CONCLUSIONYGC could treat PMO effectively, as it could obviously increase the BMD of lumbar vertebrae and coxafemoral bone, elevate the alleviating rate of ostealgia and incessant motion time, yet causing no newly found compressive fracture of vertebrae, or and any related adverse reaction. YGC could not only promote the formation, but also inhibit the absorption of bone as well as increase the sex hormone level. Therefore, it is a pure Chinese herbal compound preparation worthy of further research and development.
Administration, Oral ; Aged ; Amidohydrolases ; urine ; Bone Density ; drug effects ; Bone and Bones ; drug effects ; metabolism ; Calcium ; administration & dosage ; blood ; urine ; Drugs, Chinese Herbal ; administration & dosage ; adverse effects ; Female ; Fractures, Bone ; epidemiology ; prevention & control ; Gonadal Steroid Hormones ; blood ; Humans ; Hydroxyproline ; urine ; Incidence ; Middle Aged ; Osteoporosis, Postmenopausal ; drug therapy ; metabolism ; Prospective Studies ; Treatment Outcome
7.A new software method for accurate mass measurements of drugs on unit mass resolution mass spectrometer.
Ke LIU ; Bin MA ; Yong-dong WANG ; Xiao-yan CHEN ; Da-fang ZHONG
Acta Pharmaceutica Sinica 2007;42(10):1112-1114
Accurate mass measurements of 20 drugs were conducted using MassWorks software on a TSQ Quantum Ultra mass spectrometer. All Q1 scan mass spectral data were collected in profile mode with full width at half-maximum (FWHM) set at 0.7 Da. The mass errors of all 20 drugs (molecular weight between 135 and 810) were within the range from -22.4 x 10(-6) to 36. 1 x 10(-6), among them 90% of the drugs achieved a mass accuracy better than 10 x 10(-6). The new method can provide accurate mass measurements on unit mass resolution mass spectrometers.
Molecular Weight
;
Pharmaceutical Preparations
;
analysis
;
Software
;
Spectrometry, Mass, Electrospray Ionization
;
methods
8.Expression of human beta-defensin 3 in COS-7 cell.
Xiao-ye TUO ; Ming-da XU ; Bi CHEN ; Jia-ke CHAI ; Zhi-yong SHENG
Chinese Medical Sciences Journal 2004;19(3):207-211
OBJECTIVETo establish a cell line for stable expression of human beta-defensin 3 (hBD3).
METHODSFull length cDNA of hBD3 was isolated from previously constructed pGEM-hBD3 and then inserted into pcDNA3. The recombinant vector identified carrying hBD3 with right direction was introduced into COS-7 cells by Lipofectamine. Cell clones survived in G418-rich medium and with stable expression of hBD3 in both mRNA and protein levels were identified by RT-PCR and Western blot respectively. Genomic integration of the hBD3 gene with the COS-7 cells was confirmed by Southern dot blot and primary analysis. The antimicrobial activity of the secreted hBD3 was also evaluated.
RESULTSCOS-7 cells transfected with pcDNA3-hBD3 expressed hBD3 stably in mRNA and protein level. Southern dot blot analysis showed successful integration of the hBD3 gene into the genome of COS-7 cell and the hBD-3 protein secreted into the culture medium showed antimicrobial activity.
CONCLUSIONWe successfully established a hBD3-expressing cell line.
Animals ; COS Cells ; Cercopithecus aethiops ; Escherichia coli ; drug effects ; Genetic Vectors ; RNA, Messenger ; biosynthesis ; genetics ; Recombinant Proteins ; biosynthesis ; genetics ; Staphylococcus aureus ; drug effects ; Transfection ; beta-Defensins ; biosynthesis ; genetics ; pharmacology
9.Investigation on dissolution of cinnabar in vitro.
Ke-wu ZENG ; Qi WANG ; Xiao-da YANG ; Kui WANG
China Journal of Chinese Materia Medica 2007;32(3):231-234
OBJECTIVETo study effects of different chemical factors in gastrointestinal tract, i.e. pH, protein, amino acid, ionic strength, Na2S, on the dissolution of cinnabar.
METHODThe content of total mercury in various dissolution of cinnabar were analyzed by UV/VIS Spectrophotometer. The particle distributions in dissolution of cinnabar were measured by Laser Particle Size Analyzer. The constituents of dissoluble substance of cinnabar in presence of Na2S were determined using ESI-MS.
RESULTThe solubility of cinnabar could be increased significantly in the presence of Na2S/So, and strong acidic pH, respectively. While the influence of thiol amino acid on promoting dissolution remains relatively low. Cinnabar didnt dissolve mainly in the form of nanoparticle.
CONCLUSIONWe postulated that cinnabar could be dissolved in various forms of mercury complexes containing sulphur.
Cysteine ; chemistry ; Hydrogen-Ion Concentration ; Mercury Compounds ; analysis ; chemistry ; Particle Size ; Solubility ; Spectrometry, Mass, Electrospray Ionization ; Spectrophotometry, Ultraviolet ; Sulfites ; chemistry
10.Sensitizing effect of recombinant human PDCD5 protein on chemotherapy of acute monocytic leukemia cell line U937 and its mechanism.
Yan-Fang WANG ; Quan-Sheng SONG ; Ying-Mei ZHANG ; Da-Long MA ; Ying WANG ; Xiao-Yan KE
Journal of Experimental Hematology 2010;18(2):277-281
This study was aimed to investigate the sensitizing effect of recombinant human PDCD5 (rhPDCD5) protein on chemotherapy of U937 cell line and its mechanism. The flow cytometry was performed to assess the changes of cell apoptosis and cell cycle influenced by rhPDCD5. Hochst 33258 staining was used to observe morphology of the apoptotic cells. The activity change of caspase-3 was detected to analyse the possible mechanisms of rhPDCD5-induced apoptosis. RT-PCR was performed to observe the expression level of drug-resistant genes. The results showed that the percentage of apoptotic cells and the activity of caspase-3 remarkably increased in U937 cells treated with rhPDCD5 combined with chemotherapeutic drug; the cell cycle arrest induced by anti-tumor drug was also enhanced when combined with rhPDCD5; meanwhile, the expression levels of drug-resistant genes were down-regulated in jointly treated U937 cells. It is concluded that the chemosensitizing mechanisms of rhPDCD5 are complex. rhPDCD5 may increase the cytotoxicity of anti-tumor drugs by promoting the caspase-3-related apoptosis, influencing cell cycle, decreasing the expression of drug-resistant genes and reversing drug-resistance.
Antineoplastic Agents
;
pharmacology
;
Apoptosis
;
drug effects
;
Apoptosis Regulatory Proteins
;
pharmacology
;
Caspase 3
;
metabolism
;
Cell Cycle
;
drug effects
;
Drug Resistance, Neoplasm
;
drug effects
;
Humans
;
Neoplasm Proteins
;
pharmacology
;
Recombinant Proteins
;
pharmacology
;
U937 Cells